Archive - September 2019
Half of European cancer drug trials ‘biased’, says BMJ
Tresiba lowers risk of hypos in type II diabetes
Sertraline improves anxiety, but ‘unlikely’ to treat depression
‘New era’ of precision medicine for children with cancer
Four Health, ARK top the PM Society Digital Awards 2019
Four Health and ARK among winners at PM Society Digital Awards
Democrats’ final pricing plan announced, 250 drugs targeted
Insys gets bankruptcy court okay for Subsys sale